These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18548044)

  • 1. Translational research: the full cycle.
    Ledford H
    Nature; 2008 Jun; 453(7197):843-5. PubMed ID: 18548044
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical research: Gene-therapy reboot.
    Cassiday L
    Nature; 2014 May; 509(7502):651-3. PubMed ID: 24877176
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy for SCID-X1: focus on clinical data.
    Baum C
    Mol Ther; 2011 Dec; 19(12):2103-4. PubMed ID: 22134740
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer: understanding the target.
    Stratton MR; Futreal PA
    Nature; 2004 Jul; 430(6995):30. PubMed ID: 15229590
    [No Abstract]   [Full Text] [Related]  

  • 5. Case of leukaemia associated with X-linked severe combined immunodeficiency gene therapy trial in London.
    Board of the European Society of Gene and Cell Therapy
    Hum Gene Ther; 2008 Jan; 19(1):3-4. PubMed ID: 18380015
    [No Abstract]   [Full Text] [Related]  

  • 6. Trial watch: Self-inactivating gene-therapy vector alleviates safety concerns.
    Cully M
    Nat Rev Drug Discov; 2014 Dec; 13(12):879. PubMed ID: 25394873
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward Clinical Translation of New Gene Targeting Technologies for Correcting Inherited Mutations and Empowering Adoptive Immunotherapy of Cancer (SUPERSIST).
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):95-7. PubMed ID: 26086760
    [No Abstract]   [Full Text] [Related]  

  • 8. Trials are halted on gene therapy: child in experiment falls ill--new setback for research.
    Stolberg SG
    N Y Times Web; 2002 Oct; ():A1, A25. PubMed ID: 12474837
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157. 1993.
    Noguchi M; Yi H; Rosenblatt HM; Filipovich AH; Adelstein S; Modi WS; McBride OW; Leonard WJ
    J Immunol; 2008 Nov; 181(9):5817-27. PubMed ID: 18941169
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome editing: a tool for research and therapy: targeted genome editing hits the clinic.
    Lombardo A; Naldini L
    Nat Med; 2014 Oct; 20(10):1101-3. PubMed ID: 25295939
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards safe therapy for immunodeficiency.
    Tsai SQ
    Nat Biomed Eng; 2017 Dec; 1(12):937-938. PubMed ID: 31015711
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of Mutations in the IL2RG Gene in 2 Asian Infants With X-linked Severe Combined Immunodeficiency.
    Hara Y; Kobayashi N; Maruyama Y; Motobayashi M; Shigemura T; Ohara O; Agematsu K; Koike K
    J Investig Allergol Clin Immunol; 2015; 25(4):313-5. PubMed ID: 26310054
    [No Abstract]   [Full Text] [Related]  

  • 13. New Gene Therapy Potential Cure for "Bubble Boy Disease": An experimental gene therapy has allowed children with SCID-1X to develop fully functioning immune systems.
    Am J Med Genet A; 2019 Jul; 179(7):1114-1115. PubMed ID: 31180192
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel IL2RG mutation presenting with atypical T(-)B(+)NK+ phenotype: rapid elucidation of NK cell origin.
    Estévez OA; Ortega C; Fernández S; Aguado R; Rumbao J; Perez-Navero J; Santamaría M
    Pediatr Blood Cancer; 2014 Jan; 61(1):178-9. PubMed ID: 23940110
    [No Abstract]   [Full Text] [Related]  

  • 15. LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia.
    Ruggero K; Al-Assar O; Chambers JS; Codrington R; Brend T; Rabbitts TH
    Leukemia; 2016 Sep; 30(9):1959-62. PubMed ID: 27256700
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA halts 27 gene therapy trials after illness: leukemia-like cases in 2 children in France prompt the action.
    Pollack A
    N Y Times Web; 2003 Jan; ():A1, A17. PubMed ID: 12647754
    [No Abstract]   [Full Text] [Related]  

  • 17. Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency.
    Strauss BE; Costanzi-Strauss E
    Braz J Med Biol Res; 2007 May; 40(5):601-13. PubMed ID: 17464421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting the right patient for tumor therapy.
    Arteaga CL
    Nat Med; 2004 Jun; 10(6):577-8. PubMed ID: 15170197
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
    Kaiser J
    Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell-replete haploidentical bone marrow transplantation for X-linked severe combined immunodeficiency.
    Ariffin H; Chew KS; Jawin V; Thavagnanam S
    Singapore Med J; 2020 May; 61(5):284-285. PubMed ID: 30128577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.